Egetis Therapeutics AB (publ) (EGTX) — Cash Flow Quality Index

Latest as of March 2019: 1.22x

Egetis Therapeutics AB (publ) (EGTX) has a Cash Flow Quality Index of 1.22x as of March 2019. Operating cash flow of Skr28.02 Million exceeds net income of Skr22.89 Million, indicating high earnings quality where cash backs reported profits. Also explore Egetis Therapeutics AB (publ) (EGTX) total assets for the complete picture of this company's asset base.

Cash Flow Quality Index

1.22x

Operating CF / Net Income

Operating Cash Flow

Skr28.02 Million

SEK

Net Income

Skr22.89 Million

SEK

Data as of

Mar 2019

Most recent filing

Annual Cash Flow Quality Index for Egetis Therapeutics AB (publ) (None–None)

Year-by-year earnings quality comparison for Egetis Therapeutics AB (publ). For live market cap and the full company financial profile, see Egetis Therapeutics AB (publ) (EGTX) market capitalisation.

Year	Quality Index	Operating CF (SEK)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.